Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.
暂无分享,去创建一个
H. Goldschmidt | M. Dimopoulos | A. Jakubowiak | D. Siegel | A. Stewart | H. Ludwig | T. Facon | J. San-Miguel | M. Obreja | J. Blaedel | A. Stewart